Expression of Niban in renal interstitial fibrosis

Nephrology

Volumn 19, Issue 8, 2014, Pages 479-489

  Liu, Jishi ^a   Qin, Jiao ^a   Mei, Wenjuan ^b   Zhang, Hao ^a   Yuan, Qiongjing ^a   Peng, Zhangzhe ^a   Luo, Renna ^a   Yuan, Xiangning ^a   Huang, Ling ^a   Tao, Lijian ^a,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

apoptosis; Chronic Kidney Disease; Niban (Fam129a); renal interstitial fibrosis

Indexed keywords

MESSENGER RNA; NIBAN PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKER; UNCLASSIFIED DRUG; FAM129A PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; RAT; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; FIBROSIS; GENETICS; KIDNEY; MALE; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BIOMARKERS, TUMOR; CELLS, CULTURED; FIBROSIS; HUMANS; KIDNEY; MALE; NEOPLASM PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84904913580     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12266     Document Type: Article

References (38)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
2. Baumeister SE, Böger CA, Krämer BK, et al. Effect of chronic kidney disease and comorbid conditions on health care costs: A 10-year observational study in a general population. Am. J. Nephrol. 2010; 31: 222-229.
3. Meguid ELNA, Bello AK,. Chronic kidney disease: The global challenge. Lancet 2005; 365 (9456): 331-340.
4. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS,. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 2003; 41: 1-12.
5. Zhang L, Zuo L, Xu G, et al. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol. Dial. Transplant. 2007; 22: 1093-1099.
6. Chen W, Wang H, Dong XQ, et al. Epidemiologic study of chronic kidney disease in Guangzhou urban area (in Chinese). Chin. J. Nephrol. 2007; 23: 147-151.
7. Guo LZ, Zhang LX, Wang XG, et al. Screening for chronic kidney disease in a village of Zhejiang province (in Chinese). Chin. J. Nephrol 2007; 23: 152-156.
8. Gilbertson D, Solid C, Xue JL, Collins AJ,. Projecting the U.S. ESRD population by 2030. US Renal Data System: Data presented at the 2003 American Society of Nephrology Annual Meeting. 2003. [Cited May 2014.] Available from URL: http://www.usrds.org/2003/pres/html/5U-ASN-projections-files/frame.htm
9. Lin SL, Kisseleva T, Brenner DA, Duffield JS,. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 2008; 173: 1617-1627.
10. Boor P, Ostendorf T, Floege J,. Renal fibrosis: Novel insights into mechanisms and therapeutic targets. Nat. Rev. Nephrol 2010; 6: 643-656.
11. Chevalier RL,. Obstructive nephropathy: Towards biomarker discovery and gene therapy. Nat. Clin. Pract. Nephrol. 2006; 2: 157-168.
12. Liu Q, Liu S, Shi Y, et al. Suppressors of cytokine signaling inhibit tubular epithelial cell-myofibroblast transdifferentiation. Am. J. Nephrol. 2011; 34: 142-151.
13. Manucha W,. Biochemical-molecular markers in unilateral ureteral obstruction. Biocell 2007; 31: 1-2.
14. Bascands JL, Schanstra JP,. Obstructive nephropathy: Insights from genetically enginerred animals. Kidney Int. 2005; 68: 925-937.
15. Franke EI, Vanderbrink BA, Hile KL, et al. Renal IL-18 production is macrophage independent during obstructive injury. PLoS ONE 2012; 7: e47417.
16. Poucell-Hatton S, Huang M, Bannykh S, Benirschke K, Masliah E,. Fetal obstructive uropathy: Patterns of renal pathology. Pediatr. Dev. Pathol. 2000; 3: 223-231.
17. Winyard PJ, Nauta J, Lirenman DS, et al. Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int. 1996; 49: 135-146.
18. Majima S, Kajino K, Fukuda T, Otsuka F, Hino O,. A novel gene 'Niban' upregulated in renal carcinogenesis: Cloning by the cDNA-amplified fragment length polymorphism approach. Jpn. J. Cancer Res. 2000; 91: 869-874.
19. Adachi H, Majima S, Kon S, et al. Niban gene is commonly expressed in the renal tumors: A new candidate marker for renal carcinogenesis. Oncogene 2004; 23: 3495-3500.
20. Ito S, Fujii H, Matsumoto T, Abe M, Ikeda K, Hino O,. Frequent expression of Niban in head and neck squamous cell carcinoma and squamous dysplasia. Head Neck 2010; 32: 96-103.
21. Ji H, Ding Z, Hawke D, et al. AKT-dependent phosphorylation of Niban regulates nucleophosmin-and MDM2-mediated p53 stability and cell apoptosis. EMBO Rep. 2012; 13: 554-560.
22. Sun GD, Kobayashi T, Abe M, et al. The endoplasmic reticulum stress-inducible protein Niban regulates eIF2alpha and S6K1/4E-BP1 phosphorylation. Biochem. Biophys. Res. Commun. 2007; 360: 181-187.
23. Lan HY, Mu W, Tomita N, et al. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J. Am. Soc. Nephrol. 2003; 14: 1535-1548.
24. Yuan Q, Wang R, Peng Y, et al. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation. Am. J. Nephrol. 2011; 34: 181-194.
25. Broekema M, Harmsen MC, van Luyn MJ, et al. Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats. J. Am. Soc. Nephrol. 2007; 18: 165-175.
26. Jin J, Park J, Kim K, et al. Detection of differential proteomes of human beta-cells during isletlike differentiation using iTRAQ labeling. J. Proteome Res. 2009; 8: 1393-1403.
27. Guo Y, Singleton PA, Rowshan A, et al. Quantitative proteomics analysis of human endothelial cell membrane rafts: Evidence of MARCKS and MRP regulation in the sphingosine 1-phosphate-induced barrier enhancement. Mol. Cell. Proteomics 2007; 6: 689-696.
28. Zhang X, Li Y, Dai C, Yang J, Mundel P, Liu Y,. Sp1 and Sp3 transcription factors synergistically regulate HGF receptor gene expression in kidney. Am. J. Physiol. Renal Physiol. 2003; 284: F82-94.
29. Bing-xin L, Yi-ting T, Wei W, et al. Fluorofenidone attenuates renal interstitial fibrosis in the rat model of obstructive nephropathy. Mol Cell Bio 2011; 345: 263-273.
30. Capozzi V, Arena MP, Crisetti E, Spano G, Fiocco D,. The hsp 16 gene of the probiotic lactobacillus acidophilus is differently regulated by salt, high temperature and acidic stresses, as revealed by reverse transcription quantitative PCR (qRT-PCR) analysis. Int. J. Mol. Sci. 2011; 12: 5390-5405.
31. Liu XD, Fan RF, Zhang Y, et al. Down-regulation of telomerase activity and activation of caspase-3 are responsible for tanshinone I-induced apoptosis in monocyte leukemia cells in vitro. Int. J. Mol. Sci. 2010; 11: 2267-2280.
32. Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP,. Predicting renal outcome in IgA nephropathy. J. Am. Soc. Nephrol. 1997; 8: 199-207.
33. Zhou TB, Zeng ZY, Qin YH, Zhao YJ,. Less expression of prohibitin is associated with increased paired box 2 (PAX2) in renal interstitial fibrosis rats. Int. J. Mol. Sci. 2012; 13: 9808-9825.
34. Yuan Q, Wang L, Zhang F, et al. Fluorofenidone suppresses epithelial-mesenchymal transition and the expression of connective tissue growth factor via inhibiting TGF-beta/Smads signaling in human proximal tubular epithelial cells. Pharmazie 2011; 66: 961-967.
35. García-Sánchez O, Lõpez-Hernández FJ, Lõpez-Novoa JM,. An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease. Kidney Int. 2010; 77: 950-955.
36. Nangaku M,. Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J. Am. Soc. Nephrol. 2006; 17: 17-25.
37. Miyajima A, Chen J, Lawrence C, et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int. 2000; 58: 2301-2313.
38. Xu Y, Yang S, Huang J, Ruan S, Zheng Z, Lin J,. TGF-β1 induces autophagy and promotes apoptosis in renal tubular epithelial cells. Int. J. Mol. Med. 2012; 29: 781-790.